000			02208 a2200697 4500
005			20250513101413.0
264		0	_c19970227
008			199702s 0 0 eng d
022			_a0268-3369
040			_aNLM _beng _cNLM
100	1		_aStyler, M J
245	0	0	_aHepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysis. _h[electronic resource]
260			_bBone marrow transplantation _cJul 1996
300			_a171-6 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAnti-Bacterial Agents _xadverse effects
650	0	4	_aBone Marrow Transplantation
650	0	4	_aBusulfan _xadverse effects
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aCiprofloxacin _xadverse effects
650	0	4	_aCyclophosphamide _xadverse effects
650	0	4	_aEstrogens _xadverse effects
650	0	4	_aFemale
650	0	4	_aGenetic Diseases, Inborn _xtherapy
650	0	4	_aGraft vs Host Disease _xprevention & control
650	0	4	_aHepatic Veno-Occlusive Disease _xchemically induced
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xadverse effects
650	0	4	_aIncidence
650	0	4	_aLife Tables
650	0	4	_aLiver Diseases _xcomplications
650	0	4	_aLiver Function Tests
650	0	4	_aMale
650	0	4	_aMethotrexate _xadverse effects
650	0	4	_aMiddle Aged
650	0	4	_aMultiple Organ Failure _xchemically induced
650	0	4	_aMultivariate Analysis
650	0	4	_aNeoplasms _xtherapy
650	0	4	_aProgestins _xadverse effects
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Factors
650	0	4	_aTransplantation Conditioning _xadverse effects
650	0	4	_aVancomycin _xadverse effects
700	1		_aCrilley, P
700	1		_aBiggs, J
700	1		_aMoul, J
700	1		_aCopelan, E
700	1		_aTopolsky, D
700	1		_aAvalos, B
700	1		_aPenza, S
700	1		_aSabol, P
700	1		_aDowns, K
700	1		_aSzer, J
700	1		_aBrodsky, I
700	1		_aMarks, D I
773	0		_tBone marrow transplantation _gvol. 18 _gno. 1 _gp. 171-6
999			_c8826225 _d8826225